DTL
ACOR

Dynamic Technology Lab’s Acorda Therapeutics ACOR Stock Holding History

Dynamic Technology Lab’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-63
Closed -$218K – 1439
2018
Q2 		$218K Buy
+63
New +$193K 0.03% 817
2017
Q1 		– Sell
-113
Closed -$255K – 1340
2016
Q4 		$255K Buy
+113
New +$269K 0.07% 599
2016
Q2 		– Sell
-118
Closed -$373K – 1228
2016
Q1 		$373K Buy
+118
New +$490K 0.1% 407
2015
Q4 		– Sell
-70
Closed -$223K – 1189
2015
Q3 		$223K Buy
+70
New +$271K 0.08% 592
2013
Q4 		– Sell
-57
Closed -$235K – 725
2013
Q3 		$235K Buy
+57
New +$246K 0.19% 260

Other funds holding ACOR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dynamic Technology Lab's ACOR Position: Q3 2018 in Review

Dynamic Technology Lab sold out of Acorda Therapeutics (ACOR) in Q3 2018, closing a stake of 63 shares — an estimated $218K sold.

Dynamic Technology Lab first reported a position in ACOR in Q3 2013 and held it in 5 quarters. The position peaked at $373K in Q1 2016. 174 funds tracked by Wall St. Rank hold ACOR as of Q3 2018.

  • Dynamic Technology Lab reported no remaining Acorda Therapeutics position as of Q3 2018 after selling out during the quarter.
  • Dynamic Technology Lab sold 63 Acorda Therapeutics shares in Q3 2018, an estimated $218K.
  • Dynamic Technology Lab first reported a position in Acorda Therapeutics in Q3 2013 and held it in 5 quarters.
  • Dynamic Technology Lab's Acorda Therapeutics position peaked at $373K in Q1 2016.
  • 174 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q3 2018.

Based on Dynamic Technology Lab's 13F filing for Q3 2018, filed 14 Nov 2018.